1-154558459-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_017582.7(UBE2Q1):c.95G>A(p.Gly32Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000167 in 1,376,950 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017582.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UBE2Q1 | NM_017582.7 | c.95G>A | p.Gly32Glu | missense_variant | 1/13 | ENST00000292211.5 | NP_060052.3 | |
UBE2Q1 | XM_047424467.1 | c.95G>A | p.Gly32Glu | missense_variant | 1/12 | XP_047280423.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UBE2Q1 | ENST00000292211.5 | c.95G>A | p.Gly32Glu | missense_variant | 1/13 | 1 | NM_017582.7 | ENSP00000292211 | P1 | |
UBE2Q1 | ENST00000497453.1 | n.122-94G>A | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000667 AC: 10AN: 149816Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000128 AC: 5AN: 39164Hom.: 0 AF XY: 0.0000817 AC XY: 2AN XY: 24478
GnomAD4 exome AF: 0.0000106 AC: 13AN: 1227024Hom.: 0 Cov.: 30 AF XY: 0.0000116 AC XY: 7AN XY: 602568
GnomAD4 genome AF: 0.0000667 AC: 10AN: 149926Hom.: 0 Cov.: 31 AF XY: 0.0000819 AC XY: 6AN XY: 73268
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 04, 2024 | The c.95G>A (p.G32E) alteration is located in exon 1 (coding exon 1) of the UBE2Q1 gene. This alteration results from a G to A substitution at nucleotide position 95, causing the glycine (G) at amino acid position 32 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at